Skip to main content
Back
AKTS logo

Aktis Oncology, Inc.

Data quality: 100%
AKTS
NASDAQ Healthcare Biotechnology
$18.18
▲ $0.48 (2.71%)
Mkt Cap: 968.94M
Day Range
$17.72 $19.18
52-Week Range
$16.80 $29.16
Volume
488,201
50D / 200D Avg
$19.69 / $19.69
Prev Close
$17.70

Price History

Financial Trends

Peer Comparison

vs Healthcare sector median (626 peers)

Metric Stock Sector Median
P/E -22.0 0.4
P/B 2.9
ROE % 3.8
Net Margin % -2957.6 3.9
Rev Growth 5Y % 10.0
D/E 0.2

Key Takeaways

Generating 11.90M in free cash flow
Capital intensive — 192.47% of revenue goes to capex

Growth

Revenue Growth (5Y)
N/A
Revenue (1Y)N/A
Earnings (1Y)N/A
FCF Growth (3Y)N/A

Quality

Return on Equity
N/A
ROICN/A
Net Margin-2957.63%
Op. Margin-3500.34%

Safety

Debt / Equity
N/A
Current Ratio15.98
Interest Coverage0.00

Valuation

P/E Ratio
-22.03
P/B RatioN/A
EV/EBITDAN/A
Dividend Yield0.00%

All Fundamental Metrics

Growth
Revenue Growth (1Y) N/A Revenue Growth (3Y) N/A
Earnings Growth (1Y) N/A Earnings Growth (3Y) N/A
Revenue Growth (5Y) N/A Earnings Growth (5Y) N/A
Profitability
Revenue (TTM) 1.49M Net Income (TTM) -43.98M
ROE N/A ROA -13.48%
Gross Margin 100.00% Operating Margin -3500.34%
Net Margin -2957.63% Free Cash Flow (TTM) 11.90M
ROIC N/A FCF Growth (3Y) N/A
Safety
Debt / Equity N/A Current Ratio 15.98
Interest Coverage 0.00 Dividend Yield 0.00%
Valuation
P/E Ratio -22.03 P/B Ratio N/A
P/S Ratio 651.61 PEG Ratio 0.00
EV/EBITDA N/A Dividend Yield 0.00%
Market Cap 968.94M Enterprise Value 943.79M

Income Statement

Annual, most recent first

Income statement data, annual, most recent first
Metric FY2024 FY2023 FY2022
Revenue 1.49M 0.0 0.0
Net Income -43.98M -28.64M -17.93M
EPS (Diluted) 0.00 0.00 0.00
Gross Profit 1.49M 0.0 0.0
Operating Income -52.05M -34.79M -19.76M

Balance Sheet

Annual, most recent first

Balance sheet data, annual, most recent first
Metric FY2024 FY2023 FY2022
Total Assets 326.18M 122.36M 138.32M
Total Liabilities 413.98M 168.66M 157.55M
Shareholders' Equity -87.80M -46.31M -19.23M
Total Debt 12.01M 13.40M 1.78M
Cash & Equivalents 37.16M 29.51M 128.60M
Current Assets 300.85M 100.20M 132.48M
Current Liabilities 18.82M 6.24M 5.28M